Activation of the PKR/eIF2α signaling cascade inhibits replication of Newcastle disease virus
- Shilei Zhang1Email author,
- Yingjie Sun1Email author,
- Hongjun Chen1,
- Yabin Dai2,
- Yuan Zhan1,
- Shengqing Yu1,
- Xusheng Qiu1,
- Lei Tan1,
- Cuiping Song1 and
- Chan Ding1Email author
© Zhang et al.; licensee BioMed Central Ltd. 2014
Received: 5 December 2013
Accepted: 27 March 2014
Published: 31 March 2014
Newcastle Disease virus (NDV) causes severe and economically significant disease in almost all birds. However, factors that affect NDV replication in host cells are poorly understood. NDV generates long double-stranded RNA (dsRNA) molecules during transcription of single-stranded genomic RNA. Protein kinase R (PKR) is activated by dsRNA. The aim of this study was to elucidate the role of PKR in NDV infection.
NDV infection led to the activation of dsRNA-dependent PKR and phosphorylation of its substrate, translation initiation factor eIF2α, in a dose-dependent manner by either the lentogenic strain LaSota or a velogenic strain Herts/33. PKR activation coincided with the accumulation of dsRNA induced by NDV infection. PKR knockdown remarkably decreased eIF2α phosphorylation as well as IFN-β mRNA levels, leading to the augmentation of extracellular virus titer. Furthermore, siRNA knockdown or phosphorylation of eIF2α or okadaic acid treatment significantly impaired NDV replication, indicating the critical role of the PKR/eIF2α signaling cascade in NDV infection.
PKR is activated by dsRNA generated by NDV infection and inhibits NDV replication by eIF2α phosphorylation. This study provides insight into NDV-host interactions for the development of candidate antiviral strategies.
KeywordsNewcastle disease virus dsRNA PKR eIF2α HeLa cells
The presence of viral pathogen-associated molecular patterns (PAMPs) is known to trigger innate immune reactions, especially the stimulation of genes downstream type I interferon (IFN) . Among the variety of IFN-stimulated gene products, double-stranded RNA-dependent protein kinase (PKR) is a key executor of this antiviral response . As a pattern recognition receptor (PRR) for viral dsRNA, PKR is considered to be significant for type I IFN production . The ubiquitously expressed PKR is usually present in an inactive form at a low abundance, but is activated by conformational change and autophosphorylation upon binding of dsRNA, generated during viral genome replication . PKR activation leads to the phosphorylation of its natural substrate, the alpha subunit of eukaryotic initiation factor 2 (eIF2) on serine residue 51, which increases the affinity of phosphorylated eIF2α for eIF2β, which is required for protein translation, leading to the cessation of translation and consequent inhibition of viral replication [5, 6]. PKR has been demonstrated to serve as a PRR in the mediation of IFN production in West Nile virus (WNV) infection . Consistent with WNV infection, PKR is also required for IFN production in response to other RNA viruses, including encephalomyocarditis virus, Semliki Forest virus (SFV) and Theiler’s murine encephalomyelitis virus (TMEV) . However, HCV infection arrested PKR-activated cap-dependent protein synthesis, thereby suppressing the translation of retinoic acid-inducible gene 1 (RIG-I) preventing the IFN-β induction .
Newcastle disease virus (NDV) is a member of the genus Avulavirus within the subfamily Paramyxovirinae of the Paramyxoviridae family . NDV has a negative-sense, non-segmented, single-stranded RNA genome of at least three sizes of 15,186, 15,192, and 15, 198 nucleotides (nt) . Six transcriptional units encode two surface glycoproteins, the fusion protein hemagglutinin-neuraminidase, the matrix protein, and the ribonucleoprotein complex, composed of the nucleocapsid protein (NP), a phosphoprotein, and large polymerase, which is necessary for viral transcription and replication. As is often the case, for its genomic replication, NDV first generates a full-length positive-strand antigenomic RNA and then, in turn, serves as a template for the synthesis of new negative-stranded RNA genome, which forms a dsRNA intermediate .
NDV infection reportedly leads to the upregulation of total PKR mRNA in the spleen of specific pathogen-free chickens . NDV infection can also induce PKR autophosphorylation and subsequently limit protein synthesis . Previous reports also showed that PKR is not required for induction of IFNα upon NDV infection . However, there is little information available in the literature regarding PKR inhibitory mechanisms in the context of NDV infection. In the current report, we found that the NDV lentogenic strain LaSota and velogenic strain Herts/33 both triggered PKR activation and eIF2α phosphorylation in HeLa cells. Furthermore, we demonstrated the antiviral effects of PKR and explored the role of eIF2α in response to NDV replication. Our results indicated that the PKR-induced eIF2α phosphorylation is responsible for the antiviral effect against NDV. Notably, NDV-induced IFN-β mRNA levels were decreased in PKR knockdown HeLa cells using specific short interfering RNA (siRNA) for PKR, indicating that PKR was necessary for NDV-induced IFN synthesis.
NDV infection triggers PKR activation through eIF2α phosphorylation
To investigate whether viral replication is required for NDV-induced PKR and eIF2α activation, ultraviolet (UV) light-inactivated NDV Herts/33 was used for the experiment. The results showed that neither PKR nor eIF2α was phosphorylated at all timepoints post-infection (Figure 1E) and, furthermore, indicated that PKR activation is induced by NDV infection and not by interacting cells with non-infecting virus particles. Interestingly, total PKR protein content was not increased, suggesting that IFN-induced responses were not fully activated in the early phase of NDV infection.
NDV replication generates double-stranded RNA in HeLa cells
Antiviral effect of PKR on NDV replication
To further probe the role of PKR, we established HeLa cells overexpressing PKR through transfection of pcDNA-PKR plasmids. PKR protein levels in cells overexpressing PKR were obviously increased compared to that of normal cells (Figure 3D, E). PKR overexpression resulted in a decrease of viral NP synthesis (Figure 3D). Consistently, extracellular viral yields were decreased by 4.9-fold in cells overexpressing PKR infected with NDV strain Herts/33 (Figure 3F). Collectively, these data suggested that PKR plays an antiviral role in NDV-infected cells.
eIF2α plays a critical role in NDV replication
PKR contributed to IFN-β production during NDV infection
Protein kinase PKR is known to be activated mainly by viral dsRNA molecules as well as by the dsRNA binding protein PKR activating protein (PACT) in human or retina and anterior neural fold homeobox (RAX) in mice [20, 21]. Active PKR plays multiple roles in cells by the transmission of signals to eIF2α to control translation and integration of signals from various other factors, such as P53, IкB kinase, P58, and P38 . Previous studies have shown that PKR executes its antiviral effects through control of translation or regulation of apoptosis by phosphorylation of various substrates, including eIF2α, inhibitor of IкB, interferon regulatory factor 1, and P53 [23, 24]. Many viruses have evolved various inhibitory mechanisms targeting PKR [25–27]. Viral proteins counteract the PKR pathway at different levels by sequestering dsRNA, inhibiting PKR activation, synthesizing PKR pseudosubstrates, inhibiting PKR dimerization, degrading PKR, or activating antagonist phosphatases . The correlation between PKR and NDV has been suggested by the fact that NDV infection induces PKR phosphorylation and subsequently inhibits host gene translation . A later study showed that the expression of the NDV nonstructural protein V decreased PKR activation . Although these studies primarily indicated the interaction between PKR and NDV infection, detailed evidence for its antiviral mechanism remains limited.
In the current report, we first demonstrated that the activities of phosphorylated PKR and eIF2α were gradually increased during NDV infection in both a time- and dose-dependent manner (Figure 1A–D). The fact that both the lentogenic strain La Sota and velogenic strain Herts/33 could induce the PKR/eIF2α signaling cascade indicated that this response is likely to be a general anti-NDV mechanism. It seems that Herts/33 is able to increase the fraction of phosphorylated eIF2α compared to LaSota. One hypothesis assumed that no trypsin was added in the supernatant of LaSota-infected cells. Therefore LaSota was not able to re-infect after one round of virus replication. The other proposed that the differences of nonstructural protein, such as V, between velogenic Herts/33 and lentogenic LaSota strains contribute to the phosphorylation of eIF2α. PKR and eIF2α were not phosphorylated in the cells treated with UV-inactivated viruses, indicating that NDV replication is required for PKR activation (Figure 1E). PKR is activated by intracellular dsRNA generated by various viruses, such as WNV . On the other hand, Sendai virus C protein restricted PKR activation by limiting dsRNA generation . To verify whether dsRNA is involved in PKR activation during NDV infection, mAb J2 recognizing the dsRNA molecules was used to confirm the generation of dsRNA in the cytoplasm of HeLa cells infected with either lentogenic or velogenic NDV strains, but not UV-inactivated NDV, which was consistent with the activation of PKR after NDV infection. Since UV treatment impairs the ability of NDV to replicate, leading to the inhibition of viral dsRNA generation, subsequent PKR-eIF2α signaling was blocked (Figure 2).
The antiviral effects of PKR have been observed in innate immunity responses to a variety of viral infections. Recently, Zhang et al.  reported that PKR inhibition using siRNA PKR, shRNA PKR, or a PKR inhibitor enhanced HCV1α replication and rendered Huh7.5.1 cells more susceptible to HCV1α infection, suggesting that host cells may employ PKR activation to inhibit HCV1α replication. Similarly, PKR functions as a key mediator of IFN-α in opposing HBV replication, and ectopic expression of PKR resulted in the inhibition the expression of HBV capsids with a concomitant increase of phosphorylated eIF2α . In order to determine the role of PKR in NDV infection, viral protein synthesis and extracellular viral yields were evaluated after PKR knockdown or overexpression. As expected, PKR knockdown increased NDV infection, while overexpression decreased NDV replication, thereby demonstrating the antiviral effects of PKR in NDV infection (Figure 3).
PKR was not required to inhibit host translation, but rather sped up this response through eIF2α phosphorylation . A previous study also reported that NDV infection inhibited host protein translation , reminding us that translation control by eIF2α phosphorylation might be critical for the antiviral effects of PKR. The γ134.5 protein of the herpes simplex virus 1 binds to protein phosphatase 1a (PP1) and is required to prevent the shut-off of protein synthesis resulting from phosphorylation of the a subunit of eIF-2α . Based on this, we mimic the up-regulation of eIF-2α phosphorylation by using OA, an inhibitor of the serine/theorine protein phosphatases PP1and PP2A . OA reduced intracellular NDV replication, indicating that eIF2α is required for NDV replication (Figure 4A). Furthermore, the western blot and virus titration results of the present study illustrated that NDV replication was significantly inhibited in eIF2α knockdown cells (Figure 4C and D, respectively).These results indicated that PKR inhibits NDV replication by inhibiting cap-mediated eIF2α-dependent protein synthesis .
In the present study, dsRNAs were presented as punctuate dots accumulated in NDV-infected HeLa cells, suggesting that dsRNAs might interact with cellular PRRs that recognize dsRNA to form dsRNA-PRR complexes and then mediate downstream signaling, such as the IFN pathway or nuclear translocation of nuclear factor κB [32, 33]. As a critical PRR recognizing virus dsRNA, PKR primarily acts as a viral antagonist through activation of the type I IFN signaling pathway. Since the role of PKR in type I IFN production during viral replication varies, we next evaluated the effect of PKR on IFN-β production after NDV infection. Our results showed that IFN-β production coincided with PKR/eIF2α phosphorylation during NDV infection. Moreover, PKR knockdown reduced IFN-β mRNA levels after NDV infection (Figure 5), which was contrary to the findings in previous reports that PKR deficiency did not prevent IFN-β responses to NDV infection in mouse embryonic fibroblasts . In addition, as mentioned, previous report has shown that PKR is not required for induction of IFNα upon NDV infection . Subsequently, the PKR requirement for IFN-α/β production might be virus- and strain-specific . Also, there is a reasonable possibility that these observations might be related to the different cell models used in various experiments. In addition to PKR, other PRRs, such as toll-like receptor 3 (TLR3), RIG-I, and melanoma differentiation-associated protein 5 (MDA5), could also be recognized by dsRNA. Therefore, we could not rule out the possibility that other PRRs evoke IFN-β production through recognition of dsRNA generated by NDV infection [35–37]. To elucidate the mechanism of cross-talk between PKR, TLR3, and RIG/MDA5 during NDV infection, further studies are needed.
In this study, we demonstrated that NDV infection led to the activation of dsRNA-dependent PKR and phosphorylation of its substrate, eIF2α, in both a time- and dose-dependent manner. Inhibition of the PKR/eIF2α signaling cascade significantly impaired NDV infection, indicating the critical role of PKR in restricting NDV infection. The fact that PKR knockdown suppressed IFN-β production in NDV infection indicated that PKR plays an anti-NDV role via IFN-β upregulation. The results of this study should help to improve our understanding of NDV pathogenesis and provides insight for the development of candidate antiviral strategies.
Viruses and cells
NDV lentogenic strain LaSota was obtained from China Institute of Veterinary Drug Control (Beijing, China). The velogenic strain Herts/33 and recombinant NDV ZJ1 strain expressing GFP (ZJ1-GFP) were kindly provided by Xiufan Liu (Yangzhou University, Jiangsu, China) . To obtain incomplete viral replication, viral suspensions were irradiated with UV-C at 75 mWs/cm2 using a low-pressure mercury vapor discharge lamp . The absence of infective viruses after UV treatment was confirmed by the lack of replication in 9-day-old chicken embryonated eggs and in DF1 monolayer cultures. The human cervical cancer cell line (HeLa) and galline embryonic fibroblast cell line (DF-1) was purchased from ATCC (Manassas, VA, USA). Both cell lines were maintained in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum (FBS; Invitrogen, Carlsbad, CA, USA), 0.1 mg/mL of streptomycin (Sigma-Aldrich, St. Louis, MO, USA), and 100 U/mL of penicillin (Sigma-Aldrich) at 37°C in an atmosphere of 5% CO2.
Rabbit polyclonal anti-total PKR (Santa Cruz Biotechnology, Inc., Dallas, TX, USA), rabbit polyclonal anti-phospho-PKR threonine 451 (Epitomics, Inc., Burlingame, CA, USA), rabbit polyclonal anti-eIF2α, rabbit polyclonal anti-phospho-eIF2α (Cell Signaling Technology, Inc., Danvers, MA, USA), and mouse monoclonal anti-β-actin antibody (Sigma-Aldrich) were used in the current study. Mouse monoclonal anti-NP mAb was generated using the NP of LaSota strain as an antigen expressed in a prokaryotic system. Briefly, sequences encoding the full length of NP gene was amplified by reverse transcription polymerase chain reaction and cloned into the bacterial expression vector pET32a (Novagen, Madison, WI, USA) in order to express the histidine-tagged protein heterologously in Eshcerichia coli strain BL21. The expression was induced by treatment with 0.5 mM isopropyl-β-D-thiogalactopyranoside at 37°C for 4 h, and the expression product was purified using a His Band kit (Novagen) according to the manufacturer’s instructions. BALB/c mice were immuned by purified proteins for 4 times and sacrificed. The spleen of BALB/c mice was obtained for monoclonal antibodies preparation as previously .
Viral infection and drug treatment
HeLa cells were infected with NDV at an MOI of 1 at 37°C. For dose-dependent assay, HeLa cells were infected with different doses (0.5 MOI, 1 MOI, and 2 MOI) of NDV. After a 1-h absorption period, the cells were washed three times with cold phosphate-buffered saline (PBS) to remove unattached viruses and then cultured in DMEM containing 1% FBS. At 6, 12 and 24 hpi, the cell pellets and supernatant were harvested and stored at −80°C for further use. The replication of NDV in the cells was determined as the expression of NDV NP protein with monoclonal antibody against NDV NP protein using western blotting. Extracellular viral yields in cell supernatant were determined by estimating the median tissue culture infective dose (TCID50) in DF1 cells using the Reed and Muench method . In the transfection assay, cells were transfected with eukaryotic expression plasmids or siRNA using lipofectamine 2000 transfection reagent (Invitrogen). 24 h (plasmid transfection) or 48 h (siRNA transfection) post transfection, cells were infected with NDV at an MOI of 1 and harvested at 12 hpi. For pharmacological experiments, HeLa cells were infected with ZJ1-GFP at an MOI of 1 or mock infected for 9 h in the presence of OA (10 nM). The number of GFP-positive cells was quantified in 10 randomly chosen fields (magnification × 100) using Image J software (http://imagej.nih.gov/ij).
HeLa cells were lysed in lysis buffer (50 mM Tris–HCl, pH 8.0, 150 mM NaCl, 20 mM NaF, 1 mM ethylenediaminetetraacetic acid, 1% Triton, 1 mM phenylmethylsulfonyl fluoride, 1 mM ethylene glycol tetra-acetic acid, 20 mM Na4P2O7, 1 mM Na3VO4) containing the protease inhibitors leupeptin (0.5 μg/mL), aprotinin (0.5 μg/mL), and pepstatin (0.7 μg/mL). Cells were sonicated for 1 second using a Vibra Cell VCX130 sonicator (Sonics Vibra cell; Sonics & Material, Newtown, CT, USA), boiled for 5 min, and then cleared by centrifugation for 10 min at 12,000 g at 4°C. The lysates were further denatured by incubation for 5 min at 95°C in SDS-PAGE sample loading buffer (Beyotime, Nantong, China). The samples were further separated on 10% polyacrylamide gel (Bio-Rad Laboratories, Inc., Hercules, CA, USA), and transferred to a nitrocellulose membrane at 250 mA for 90 min, and then blocked using Tris buffered saline (TBS) solution containing 0.1% Tween 20 and 5% non-fat milk for 2 h. The membrane was incubated overnight at 4°C with the indicated antibodies. After washing three times with TBS/0.1% Tween 20, the membrane was exposed to horseradish peroxidase-conjugated anti-rabbit or anti-mouse IgG antibody (Sigma-Aldrich) at a dilution of 1:10000 for 2 h at room temperature. The protein bands were visualized with an enhanced chemiluminescent reagent (Pierce Biotechnology, Rockford, IL, USA) and quantified using Image J software.
Plasmid construction and transfection
Human PKR cDNA was amplified from HeLa cell mRNA and inserted into the HindIII/XhoI sites of pcDNA3.1(+) to construct pcDNA3.1-PKR. The purified plasmid DNA was prepared using the HiSpeed plasmid maxi kit (Qiagen, Hilden, Germany). The transfection procedure was performed essentially as described in the manufacturer’s instructions, but with minor modifications. Briefly, HeLa cells (1 × 106/well) were seeded into each well of a 6-well tissue culture plate and cultured at 37°C overnight. On the following day, 2 μg of plasmid was incubated for 45 min with 5 μL of Lipofectamine 2000 transfection reagent (Invitrogen) and then the transfection was allowed to occur overnight before the media was replaced with fresh DMEM. At 24 h post-transfection (hpt), cells were infected with Herts/33 strain at an MOI of 1 and harvested at 12 hpi.
Short interfering RNA oligos against PKR or eIF2α targeted to specific sequences (siPKR: 5′-GCGAGAAACUAGACAAAGU -3′ ; eIF2α: 5′-GAGAGGCUUGAAAGAGAAA-3′ ; non-targeting siRNA oligos: 5′-UUCUCCGAACGUGUCACGU-3′) were custom synthesized by GenePharma (Shanghai) Co., Ltd. (Shangai, China). HeLa cells were cultured to 60–70% confluency in a 6-well plate at 37°C overnight. PKR-specific siRNA, eIF2α-specific siRNA, and nontargeting siRNA as a negative control (100 pmol/well) were transfected with Lipofectamine 2000 according to the manufacturer’s instructions. At 6 hpt, the culture media was replaced with DMEM supplemented with 1% FBS (v/v). After a 48-h incubation period, the transfected cells were infected with NDV strain Herts/33 at an MOI of 1 and harvested at 12 hpi.
Total RNA of HeLa cells infected with NDV strain Hert/33 or PKR-silenced HeLa cells were extracted using the RNeasy kit (Qiagen, Valencia, CA, USA) and then reverse transcribed to cDNA using the SuperScript® III First-Strand Synthesis System kit (Invitrogen) with oligo dT primers (Invitrogen) . To determine mRNA levels of IFN-β and β-actin, real-time PCR was performed using the SYBR Premix Ex Taq kit (TaKaRa Biotechnology (Dalian) Co., Ltd., Dalian, China) according to the instruction manual. The specific primers targeting IFN-β (forward: 5′-ACGACAGCTCTTTCCATGA-3′; reverse: 5′-AGCCAGTGCTCGATGAATCT-3′) and β-actin (forward: 5′-GATCTGGCACCACACCTTCT-3′; reverse: 5′-GGGGTGTTGAAGGTCTCAAA-3′) used in this study were described previously [43, 44]. The expression levels of target mRNA were normalized to that of β-actin and calculated by the comparative CT method using the formula: fold change = 2−ΔΔCT, where ΔΔCT = [(CT target mRNAs –CT β-actin) in HeLa cells infected with NDV – (CT target mRNAs – CT β-actin) in mock cells] .
HeLa cells were grown on coverslips overnight and infected with NDV strain Herts/33 at an MOI of 1 or stimulated with poly (I:C) for 12 h. Cells were fixed in 3% paraformaldehyde, permeabilized with 0.5% Triton X-100 for 10 min, incubated in blocking buffer (3% BSA/PBS), and then stained with mouse mAb J2 (Scicons, Hungary) followed by Cy3-labeled goat anti-mouse IgG (Beyotime). Nuclei were stained with 4’,6-diamidino-2-phenylindole (DAPI) (Thermo Fisher Scientific Inc., Rockford, IL, USA) at a dilution of 1:500 for 10 min, and then the coverslips were mounted on slide glasses and visualized using a fluorescence microscope (Nikon Eclipse 80i; Nikon, Tokyo, Japan).
Data were expressed as means ± standard deviations. Significance was determined with the two-tailed independent Student’s t test (p < 0.05) between two groups. One-way ANOVA followed by Tukey’s test was used to compare multiple groups (>2).
We wish to thank Professor Xiufan Liu (Yangzhou University) for providing NDV strain Herts/33 and ZJ1-GFP. This work was financially supported by grants from the Chinese National High-tech R&D Program (863 Program) (2011AA10A209), the National Natural Science Foundation of China (31372421), the Chinese Special Fund for Agro-scientific Research in the Public Interest (201003012, 201303033 and 201303038).
- Garcia-Sastre A, Biron CA: Type 1 interferons and the virus-host relationship: a lesson in detente. Science 2006, 312:879–882. 10.1126/science.1125676View ArticlePubMed
- Garcia MA, Gil J, Ventoso I, Guerra S, Domingo E, Rivas C, Esteban M: Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol Mol Biol Rev 2006, 70:1032–1060. 10.1128/MMBR.00027-06View ArticlePubMed CentralPubMed
- Diebold SS, Montoya M, Unger H, Alexopoulou L, Roy P, Haswell LE, Al-Shamkhani A, Flavell R, Borrow P, Reis e Sousa C: Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature 2003, 424:324–328. 10.1038/nature01783View ArticlePubMed
- Zamanian-Daryoush M, Mogensen TH, DiDonato JA, Williams BR: NF-kappaB activation by double-stranded-RNA-activated protein kinase (PKR) is mediated through NF-kappaB-inducing kinase and IkappaB kinase. Mol Cell Biol 2000, 20:1278–1290. 10.1128/MCB.20.4.1278-1290.2000View ArticlePubMed CentralPubMed
- Hershey JW: Translational control in mammalian cells. Annu Rev Biochem 1991, 60:717–755. 10.1146/annurev.bi.60.070191.003441View ArticlePubMed
- Sudhakar A, Ramachandran A, Ghosh S, Hasnain SE, Kaufman RJ, Ramaiah KV: Phosphorylation of serine 51 in initiation factor 2 alpha (eIF2 alpha) promotes complex formation between eIF2 alpha(P) and eIF2B and causes inhibition in the guanine nucleotide exchange activity of eIF2B. Biochemistry 2000, 39:12929–12938. 10.1021/bi0008682View ArticlePubMed
- Gilfoy FD, Mason PW: West Nile virus-induced interferon production is mediated by the double-stranded RNA-dependent protein kinase PKR. J Virol 2007, 81:11148–11158. 10.1128/JVI.00446-07View ArticlePubMed CentralPubMed
- Schulz O, Pichlmair A, Rehwinkel J, Rogers NC, Scheuner D, Kato H, Takeuchi O, Akira S, Kaufman RJ, Reis e Sousa C: Protein kinase R contributes to immunity against specific viruses by regulating interferon mRNA integrity. Cell Host Microbe 2010, 7:354–361. 10.1016/j.chom.2010.04.007View ArticlePubMed CentralPubMed
- Arnaud N, Dabo S, Maillard P, Budkowska A, Kalliampakou KI, Mavromara P, Garcin D, Hugon J, Gatignol A, Akazawa D, Wakita T, Meurs EF: Hepatitis C virus controls interferon production through PKR activation. PLoS One 2010, 5:e10575. 10.1371/journal.pone.0010575View ArticlePubMed CentralPubMed
- Nelson CB, Pomeroy BS, Schrall K, Park WE, Lindeman RJ: An outbreak of conjunctivitis due to Newcastle disease virus (NDV) occurring in poultry workers. Am J Public Health Nations Health 1952, 42:672–678. 10.2105/AJPH.42.6.672View ArticlePubMed CentralPubMed
- CAO Yong-zhong GM, Wen-bo LIU, Xiu-fan LIU: Comparison of 40 complete genome sequences of Newcastle disease virus. J Yangzhou Univ (Argricultural and Life Science Edition) 2008, 29:1–5.
- Dortmans JC, Rottier PJ, Koch G, Peeters BP: The viral replication complex is associated with the virulence of Newcastle disease virus. J Virol 2010, 84:10113–10120. 10.1128/JVI.00097-10View ArticlePubMed CentralPubMed
- Rue CA, Susta L, Cornax I, Brown CC, Kapczynski DR, Suarez DL, King DJ, Miller PJ, Afonso CL: Virulent Newcastle disease virus elicits a strong innate immune response in chickens. J Gen Virol 2011, 92:931–939. 10.1099/vir.0.025486-0View ArticlePubMed
- Takeuchi K, Komatsu T, Kitagawa Y, Sada K, Gotoh B: Sendai virus C protein plays a role in restricting PKR activation by limiting the generation of intracellular double-stranded RNA. J Virol 2008, 82:10102–10110. 10.1128/JVI.00599-08View ArticlePubMed CentralPubMed
- Smith EJ, Marie I, Prakash A, Garcia-Sastre A, Levy DE: IRF3 and IRF7 phosphorylation in virus-infected cells does not require double-stranded RNA-dependent protein kinase R or Ikappa B kinase but is blocked by Vaccinia virus E3L protein. J Biol Chem 2001, 276:8951–8957. 10.1074/jbc.M008717200View ArticlePubMed
- Silvera D, Formenti SC, Schneider RJ: Translational control in cancer. Nat Rev Cancer 2010, 10:254–266. 10.1038/nrc2824View ArticlePubMed
- Toribio R, Ventoso I: Inhibition of host translation by virus infection in vivo. Proc Natl Acad Sci U S A 2010, 107:9837–9842. 10.1073/pnas.1004110107View ArticlePubMed CentralPubMed
- Wang X, Liao Y, Yap PL, Png KJ, Tam JP, Liu DX: Inhibition of protein kinase R activation and upregulation of GADD34 expression play a synergistic role in facilitating coronavirus replication by maintaining de novo protein synthesis in virus-infected cells. J Virol 2009, 83:12462–12472. 10.1128/JVI.01546-09View ArticlePubMed CentralPubMed
- Liu YL, Hu SL, Zhang YM, Sun SJ, Romer-Oberdorfer A, Veits J, Wu YT, Wan HQ, Liu XF: Generation of a velogenic Newcastle disease virus from cDNA and expression of the green fluorescent protein. Arch Virol 2007, 152:1241–1249. 10.1007/s00705-007-0961-xView ArticlePubMed
- Ito T, Yang M, May WS: RAX, a cellular activator for double-stranded RNA-dependent protein kinase during stress signaling. J Biol Chem 1999, 274:15427–15432. 10.1074/jbc.274.22.15427View ArticlePubMed
- Patel RC, Sen GC: PACT, a protein activator of the interferon-induced protein kinase, PKR. EMBO J 1998, 17:4379–4390. 10.1093/emboj/17.15.4379View ArticlePubMed CentralPubMed
- Garcia MA, Meurs EF, Esteban M: The dsRNA protein kinase PKR: virus and cell control. Biochimie 2007, 89:799–811. 10.1016/j.biochi.2007.03.001View ArticlePubMed
- Cuddihy AR, Wong AH, Tam NW, Li S, Koromilas AE: The double-stranded RNA activated protein kinase PKR physically associates with the tumor suppressor p53 protein and phosphorylates human p53 on serine 392 in vitro. Oncogene 1999, 18:2690–2702. 10.1038/sj.onc.1202620View ArticlePubMed
- Samuel CE: The eIF-2 alpha protein kinases, regulators of translation in eukaryotes from yeasts to humans. J Biol Chem 1993, 268:7603–7606.PubMed
- Myskiw C, Arsenio J, van Bruggen R, Deschambault Y, Cao J: Vaccinia virus E3 suppresses expression of diverse cytokines through inhibition of the PKR, NF-kappaB, and IRF3 pathways. J Virol 2009, 83:6757–6768. 10.1128/JVI.02570-08View ArticlePubMed CentralPubMed
- Sharma K, Tripathi S, Ranjan P, Kumar P, Garten R, Deyde V, Katz JM, Cox NJ, Lal RB, Sambhara S, Lal SK: Influenza A virus nucleoprotein exploits Hsp40 to inhibit PKR activation. PLoS One 2011, 6:e20215. 10.1371/journal.pone.0020215View ArticlePubMed CentralPubMed
- Tu YC, Yu CY, Liang JJ, Lin E, Liao CL, Lin YL: Blocking double-stranded RNA-activated protein kinase PKR by Japanese encephalitis virus nonstructural protein 2A. J Virol 2012, 86:10347–10358. 10.1128/JVI.00525-12View ArticlePubMed CentralPubMed
- Jang J, Hong SH, Choi D, Choi KS, Kang S, Kim IH: Overexpression of Newcastle disease virus (NDV) V protein enhances NDV production kinetics in chicken embryo fibroblasts. Appl Microbiol Biotechnol 2010, 85:1509–1520. 10.1007/s00253-009-2189-zView ArticlePubMed
- Park IH, Baek KW, Cho EY, Ahn BY: PKR-dependent mechanisms of interferon-alpha for inhibiting hepatitis B virus replication. Mol Cells 2011, 32:167–172. 10.1007/s10059-011-1059-6View ArticlePubMed CentralPubMed
- Barry G, Breakwell L, Fragkoudis R, Attarzadeh-Yazdi G, Rodriguez-Andres J, Kohl A, Fazakerley JK: PKR acts early in infection to suppress Semliki Forest virus production and strongly enhances the type I interferon response. J Gen Virol 2009, 90:1382–1391. 10.1099/vir.0.007336-0View ArticlePubMed CentralPubMed
- He B, Gross M, Roizman B: The gamma134.5 protein of herpes simplex virus 1 has the structural and functional attributes of a protein phosphatase 1 regulatory subunit and is present in a high molecular weight complex with the enzyme in infected cells. J Biol Chem 1998, 273:20737–20743. 10.1074/jbc.273.33.20737View ArticlePubMed
- Der SD, Lau AS: Involvement of the double-stranded-RNA-dependent kinase PKR in interferon expression and interferon-mediated antiviral activity. Proc Natl Acad Sci U S A 1995, 92:8841–8845. 10.1073/pnas.92.19.8841View ArticlePubMed CentralPubMed
- Kumar A, Haque J, Lacoste J, Hiscott J, Williams BR: Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B. Proc Natl Acad Sci U S A 1994, 91:6288–6292. 10.1073/pnas.91.14.6288View ArticlePubMed CentralPubMed
- Yang YL, Reis LF, Pavlovic J, Aguzzi A, Schafer R, Kumar A, Williams BR, Aguet M, Weissmann C: Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J 1995, 14:6095–6106.PubMed CentralPubMed
- Loo YM, Fornek J, Crochet N, Bajwa G, Perwitasari O, Martinez-Sobrido L, Akira S, Gill MA, Garcia-Sastre A, Katze MG, Gale M Jr: Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol 2008, 82:335–345. 10.1128/JVI.01080-07View ArticlePubMed CentralPubMed
- Orinska Z, Bulanova E, Budagian V, Metz M, Maurer M, Bulfone-Paus S: TLR3-induced activation of mast cells modulates CD8+ T-cell recruitment. Blood 2005, 106:978–987. 10.1182/blood-2004-07-2656View ArticlePubMed
- Wilden H, Fournier P, Zawatzky R, Schirrmacher V: Expression of RIG-I, IRF3, IFN-beta and IRF7 determines resistance or susceptibility of cells to infection by Newcastle Disease Virus. Int J Oncol 2009, 34:971–982.PubMed
- Song H, Li J, Shi S, Yan L, Zhuang H, Li K: Thermal stability and inactivation of hepatitis C virus grown in cell culture. Virol J 2010, 7:40. 10.1186/1743-422X-7-40View ArticlePubMed CentralPubMed
- Wayner EA, Carter WG: Identification of multiple cell adhesion receptors for collagen and fibronectin in human fibrosarcoma cells possessing unique alpha and common beta subunits. J Cell Biol 1987, 105:1873–1884. 10.1083/jcb.105.4.1873View ArticlePubMed
- Romer-Oberdorfer A, Werner O, Veits J, Mebatsion T, Mettenleiter TC: Contribution of the length of the HN protein and the sequence of the F protein cleavage site to Newcastle disease virus pathogenicity. J Gen Virol 2003, 84:3121–3129. 10.1099/vir.0.19416-0View ArticlePubMed
- Rahman MM, Liu J, Chan WM, Rothenburg S, McFadden G: Myxoma virus protein M029 is a dual function immunomodulator that inhibits PKR and also conscripts RHA/DHX9 to promote expanded host tropism and viral replication. PLoS Pathog 2013, 9:e1003465. 10.1371/journal.ppat.1003465View ArticlePubMed CentralPubMed
- Kim KM, Pae HO, Zheng M, Park R, Kim YM, Chung HT: Carbon monoxide induces heme oxygenase-1 via activation of protein kinase R-like endoplasmic reticulum kinase and inhibits endothelial cell apoptosis triggered by endoplasmic reticulum stress. Circ Res 2007, 101:919–927. 10.1161/CIRCRESAHA.107.154781View ArticlePubMed
- Sun Y, Ding N, Ding SS, Yu S, Meng C, Chen H, Qiu X, Zhang S, Yu Y, Zhan Y, Ding C: Goose RIG-I functions in innate immunity against Newcastle disease virus infections. Mol Immunol 2013, 53:321–327. 10.1016/j.molimm.2012.08.022View ArticlePubMed
- Taura M, Eguma A, Suico MA, Shuto T, Koga T, Komatsu K, Komune T, Sato T, Saya H, Li JD, Kai H: p53 regulates Toll-like receptor 3 expression and function in human epithelial cell lines. Mol Cell Biol 2008, 28:6557–6567. 10.1128/MCB.01202-08View ArticlePubMed CentralPubMed
- Schmittgen TD, Livak KJ: Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008, 3:1101–1108. 10.1038/nprot.2008.73View ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.